Weekly Digest – January 2025 Weekly Digest – January 2025 29 Dec 2024: Vincerx Pharma enters into a binding term sheet for a strategic merger with Oqory Vincerx Pharma has entered into a binding term sheet for a proposed merger […]
Weekly Digest – December 2024 Weekly Digest – December 2024 27 Dec 2024: DATROWAY® approved in Japan as the first TROP-2 directed therapy for patients with previously treated unresectable or recurrent HR positive, HER2 negative breast cancer Daiichi Sankyo’s DATROWAY® […]
Weekly Digest – December 2024 Weekly Digest – December 2024 27 Dec 2024: DATROWAY® approved in Japan as the first TROP-2 directed therapy for patients with previously treated unresectable or recurrent HR positive, HER2 negative breast cancer Daiichi Sankyo’s DATROWAY® […]
Weekly Digest – December 2024 Weekly Digest – December 2024 23 Dec 2024: Porton Pharma Solutions and Dragon Sail Pharmaceutical form strategic partnership to build a new ecosystem for ADC drug development, production, and supply chain Porton Pharma Solutions and […]
Weekly Digest – December 2024 Weekly Digest – December 2024 23 Dec 2024: OBI Pharma enters collaboration with GlyTech to expand GlycOBI® enabling technologies outreach in Japan and to advance glycan production OBI Pharma, a global oncology company, and GlyTech, […]
Weekly Digest – December 2024 Weekly Digest – December 2024 20 Dec 2024: WuXi Biologics and Hangzhou DAC signed research service agreement with Aadi Bioscience on three novel ADCs WuXi Biologics and Hangzhou DAC Biotechnology have signed a research service […]
Weekly Digest – December 2024 Weekly Digest – December 2024 26 Dec 2024: IND application for a phase I/II clinical study of anti-HER2 bispecific ADC subcutaneous co-formulation JSKN033 was approved Alphamab Oncology has received approval from the CDE of the […]
Weekly Digest – December 2024 Weekly Digest – December 2024 24 Dec 2024: Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous non-small cell lung cancer voluntarily withdrawn AstraZeneca and Daiichi Sankyo have voluntarily withdrawn their marketing authorization […]
Weekly Digest – December 2024 Weekly Digest – December 2024 19 Dec 2024: Pyxis oncology announces portfolio prioritization, focusing resources on its lead clinical program, PYX-201 Pyxis Oncology announced a portfolio prioritization to focus on advancing its lead clinical program, […]
Weekly Digest – December 2024 Weekly Digest – December 2024 19 Dec 2024: CStone announces first patient enrolled in the global multicenter phase 1b clinical trial of CS5001 (ROR1 ADC) CStone Pharmaceuticals announced the enrollment of the first patient in […]
